Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 3643
Gene Symbol: INSR
INSR
0.600 CausalMutation phenotype CLINVAR
Entrez Id: 54496
Gene Symbol: PRMT7
PRMT7
0.100 CausalMutation phenotype CLINVAR
Entrez Id: 55252
Gene Symbol: ASXL2
ASXL2
0.100 CausalMutation phenotype CLINVAR
Entrez Id: 9882
Gene Symbol: TBC1D4
TBC1D4
0.100 CausalMutation phenotype CLINVAR
Entrez Id: 3643
Gene Symbol: INSR
INSR
0.600 Biomarker phenotype CTD_human Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. 10949030 2000
Entrez Id: 3643
Gene Symbol: INSR
INSR
0.600 Biomarker phenotype CTD_human To evaluate whether hyperglycaemia in two lean patients with primary severe insulin resistance due to insulin receptor (IR) mutations and diabetes mellitus could be reduced by supplement of rosiglitazone for 180 days and secondary, to evaluate the effects on plasma NEFA, TG, Apo B, PAI-1 and serum insulin. 11887975 2001
Entrez Id: 5295
Gene Symbol: PIK3R1
PIK3R1
0.600 Biomarker phenotype CTD_human [Cell biological mechanism involved in the effect of sodium selenite on improving insulin sensitivity]. 14714311 2003
Entrez Id: 3953
Gene Symbol: LEPR
LEPR
0.500 Biomarker phenotype CTD_human Arsenic induces diabetic effects through beta-cell dysfunction and increased gluconeogenesis in mice. 25367288 2014
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.500 Biomarker phenotype CTD_human In conclusion, we described a significant association between eNOS gene polymorphisms and type 2 diabetes, suggesting a new genetic susceptibility factor for hyperinsulinemia, insulin resistance, and type 2 diabetes. 12716763 2003
Entrez Id: 5562
Gene Symbol: PRKAA1
PRKAA1
0.500 Biomarker phenotype CTD_human AMP-activated protein kinase-deficient mice are resistant to the metabolic effects of resveratrol. 19934007 2010
Entrez Id: 3953
Gene Symbol: LEPR
LEPR
0.500 Biomarker phenotype CTD_human Integration of metabolomics and transcriptomics data to aid biomarker discovery in type 2 diabetes. 20567778 2010
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.500 Biomarker phenotype CTD_human These data highlight the potential utility of eNOS gene therapy in the treatment of hypertension and insulin resistance. 19008412 2009
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.500 Biomarker phenotype CTD_human Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. 11342529 2001
Entrez Id: 948
Gene Symbol: CD36
CD36
0.500 Biomarker phenotype CTD_human Transgenic expression of Cd36 in the new lines was associated with significantly decreased serum fatty acids, amelioration of insulin resistance and glucose intolerance but failed to induce any consistent changes in blood pressure as measured by radiotelemetry. 14640889 2003
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.500 Therapeutic phenotype CTD_human In vivo, insulin resistance and metabolic syndrome were associated with low PBMC SIRT1 gene and protein expression. 20068143 2010
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.500 Therapeutic phenotype CTD_human In addition, constant darkness-induced circadian misalignment in mice decreases hepatic BMAL1 and SIRT1 levels and induces IR, which can be dramatically reversed by resveratrol. 24442997 2014
Entrez Id: 3952
Gene Symbol: LEP
LEP
0.500 Therapeutic phenotype CTD_human Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. 11342529 2001
Entrez Id: 9370
Gene Symbol: ADIPOQ
ADIPOQ
0.500 Therapeutic phenotype CTD_human Dual acting and pan-PPAR activators as potential anti-diabetic therapies. 21484566 2011
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.500 Biomarker phenotype CTD_human In addition, constant darkness-induced circadian misalignment in mice decreases hepatic BMAL1 and SIRT1 levels and induces IR, which can be dramatically reversed by resveratrol. 24442997 2014
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.500 Biomarker phenotype CTD_human Together, these studies highlight the therapeutic relevance of targeting duodenal SIRT1 to reverse insulin resistance and improve glucose homeostasis in obesity and diabetes. 25849131 2015
Entrez Id: 23411
Gene Symbol: SIRT1
SIRT1
0.500 Biomarker phenotype CTD_human In vivo, insulin resistance and metabolic syndrome were associated with low PBMC SIRT1 gene and protein expression. 20068143 2010
Entrez Id: 154
Gene Symbol: ADRB2
ADRB2
0.500 Biomarker phenotype CTD_human The beta2 adrenergic receptor Gln27Glu polymorphism affects insulin resistance in patients with heart failure: possible modulation by choice of beta blocker. 19034036 2008
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.500 Therapeutic phenotype CTD_human These data highlight the potential utility of eNOS gene therapy in the treatment of hypertension and insulin resistance. 19008412 2009
Entrez Id: 3953
Gene Symbol: LEPR
LEPR
0.500 Biomarker phenotype CTD_human Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator. 28611668 2017
Entrez Id: 4846
Gene Symbol: NOS3
NOS3
0.500 Therapeutic phenotype CTD_human Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. 12947532 2003